Scientists test genetic blueprint to Fine-Tune cancer radiation
NCT ID NCT05873439
Summary
This small, early-stage study explored whether doctors could use a patient's unique tumor genetics to personalize their radiation dose. It involved people with stage 2 or 3 non-small cell lung cancer that couldn't be removed by surgery. The main goal was to see if this tailored approach was safe and feasible when given alongside standard chemotherapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NONSMALL CELL LUNG CANCER STAGE III are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
Conditions
Explore the condition pages connected to this study.